Healthcare
Bryn Pharma
Recorded February 11, 2025
Bryn is developing a new epinephrine nasal spray that improves on the EpiPen in a number of ways. Most importantly, there are no needles.
Bryn is developing a new epinephrine nasal spray that improves on the EpiPen in a number of ways. Most importantly, there are no needles.
EpicQuest [NASDAQ: EEIQ], is making highly coveted, western higher education accessible to the students around the world
Rock Fiber is revolutionizing the $100B structural materials market with its innovative and sustainable, high-performance fiber products.
Vericatch is helping the global commercial fishing industry become more sustainable, efficient, accountable, and profitable.
Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates to make cancer less lethal.
Ceresti’s Caregiver-Enabled Dementia Program is a tech-powered approach to dementia care that reduces the total cost of care by more than 30%
ZYUS Life Sciences (CVE: ZYUS) is creating a world where chronic pain is managed effectively without opioids.
ColdSnap is a new platform technology that uses pods to produce single servings of super creamy ice creams, frozen lattes, smoothies, and more
The company’s AI-powered drug development program has the potential to uncover treatments for multiple diseases and impact millions of lives.
Ingenious, patented micro-hydroelectric energy recovery system produces renewable energy from the water that flows through municipal pipes
CH4 Global has created a natural supplement that when added to a livestock feed prevents methane from being produced during digestion.
Alzheon is a clinical-stage biopharma company with a first-in-class oral treatment targeting the root cause of Alzheimer’s disease.